載入...
Therapeutic Antibodies for the Treatment of Pancreatic Cancer
Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
TheScientificWorldJOURNAL
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925140/ https://ncbi.nlm.nih.gov/pubmed/20563534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2010.103 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|